Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02660164 · ClinicalTrials.gov registry record

A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion

A clinical trial of Concussion, sponsored by Jan Medical.

Completed
Registry status
149
Enrollment target
4
Study locations

NCT02660164: Completed study of Concussion, sponsored by Jan Medical.

NCT02660164 is a study of Concussion that has completed, run by Jan Medical. The registered enrollment target is 149 participants, above the 129-participant average among 9 other Concussion trials with a reported enrollment target (16% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02660164, a study of Concussion, has completed, sponsored by Jan Medical.

COMPLETED
Registry status
149 participants
Enrollment target
4
Study locations

Study Summary

The objective of the study is to evaluate, in a blinded fashion, the effectiveness of the Nautilus BrainPulse device when used as an aid in the diagnosis of concussion.

Primary Outcome

Sensitivity and Specificity of the Nautilus BrainPulse in detecting the number of subjects experiencing concussion as compared to the number of subjects with concussion as adjudicated by a panel of medical experts. BrainPulse measurement data will be aggregated by subject over the first 10-days of recording after the concussive event, or for subjects in the Control arm, after their selection as a control subject.

Conditions Studied

Interventions

  • DEVICE Nautilus BrainPulse Recording

Study Locations (4)

Florida

  • Meli Orthopedic Centers of Excellence - Fort Lauderdale

Indiana

  • Community Hospital - Munster

Louisiana

  • Louisiana State University - Baton Rouge

Wyoming

  • University of Wyoming - Laramie

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2015-11
Est. Completion 2019-03
Jan Medical

9 total trials

What the finished NCT02660164 record still lists

NCT02660164 is an observational study that tracks outcomes without assigning an intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, above the 129-participant average among 9 other Concussion trials with a reported enrollment target (16% higher).

The record links to 1 condition, with Concussion appearing as the primary indexed condition, and to 1 intervention - of which Nautilus BrainPulse Recording is the first listed.

NCT02660164 reports a single indexed study location in Florida, Indiana, Louisiana.

Frequently Asked Questions

What is clinical trial NCT02660164 about?

NCT02660164 is a clinical study titled "A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion". The objective of the study is to evaluate, in a blinded fashion, the effectiveness of the Nautilus BrainPulse device when used as an aid in the diagnosis of concussion.

What is the current status of trial NCT02660164?

This trial is currently completed. The enrollment target is 149 participants. The study started on 2015-11. Estimated completion is 2019-03.

What conditions does trial NCT02660164 study?

This clinical trial studies the following conditions: Concussion.

What interventions are being tested in trial NCT02660164?

The interventions under investigation include: Nautilus BrainPulse Recording (DEVICE).

Who is sponsoring clinical trial NCT02660164?

This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02660164 being conducted?

This trial has 4 study locations across Florida, Indiana, Louisiana, Wyoming. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Concussion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02660164's enrollment target sits among peer trials

149 5th of 9 higher than 5 of 9 other Concussion trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Concussion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04188535 · 149 participants · NA

    Serial MRI Scans During Radiation Therapy

  • NCT05828511 · 149 participants · Phase 1

    A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02660164, the US trial registry maintained by the National Library of Medicine. NCT02660164 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.